Ceres Nanosciences

company

About

Ceres Nanosciences Inc.is a privately held life sciences company engaged in the research, development

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Product Research,Web Development
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

Ceres Nanosciences Inc. (“Ceres”) is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on its proprietary Nanotrap® technology, which captures, enriches and preserves analytes/biomarkers. Early detection of biomarkers, in particular those of low abundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs. Ceres has a broad product pipeline of advanced sample collection technologies and diagnostics, funded through federal agency grants and industry collaboration funding. Ceres’ lead product in development is a direct antigen test for the diagnosis of Lyme disease, which will be available commercially in 2015.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$14.92M
Ceres Nanosciences has raised a total of $14.92M in funding over 2 rounds. Their latest funding was raised on Apr 21, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2021 Grant $8.20M 1 National Institutes of Health (NIH) Detail
Sep 2, 2020 Grant $6.50M 1 National Institutes of Health (NIH) Detail
Jan 31, 2020 Grant $225K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
3
2
Ceres Nanosciences is funded by 2 investors. National Institutes of Health (NIH) and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health (NIH) Yes Grant
National Institutes of Health Yes Grant